Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21312Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kalambokis, G. N. | en |
| dc.contributor.author | Kosta, P. | en |
| dc.contributor.author | Pappas, K. | en |
| dc.contributor.author | Tsianos, E. V. | en |
| dc.date.accessioned | 2015-11-24T19:14:27Z | - |
| dc.date.available | 2015-11-24T19:14:27Z | - |
| dc.identifier.issn | 1007-9327 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21312 | - |
| dc.rights | Default Licence | - |
| dc.subject | Carbolines/adverse effects/*therapeutic use | en |
| dc.subject | Hemodynamics/*drug effects | en |
| dc.subject | Humans | en |
| dc.subject | Hypertension, Portal/*drug therapy/etiology/physiopathology | en |
| dc.subject | Kidney/*drug effects/physiopathology | en |
| dc.subject | Liver Cirrhosis/complications/*drug therapy/physiopathology | en |
| dc.subject | Natriuresis/drug effects | en |
| dc.subject | Phosphodiesterase Inhibitors/adverse effects/*therapeutic use | en |
| dc.subject | Vasodilator Agents/adverse effects/*therapeutic use | en |
| dc.title | Haemodynamic and renal effects of tadalafil in patients with cirrhosis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/20954291 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2010 | - |
| heal.abstract | A recent report introduced the phosphodiesterase-5 inhibition by vardenafil as a novel treatment of portal hypertension in patients with cirrhosis. In the herein presented "letter to the editor", the administration of tadalafil did not influence portal haemodynamics but impaired systemic haemodynamics in patients with cirrhosis. Our observations concur with the results of a report in a previous issue of World Journal of Gastroenterology (October 2008). Moreover, tadalafil adversely affected renal function in patients with decompensated liver disease. | en |
| heal.journalName | World J Gastroenterol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Kalambokis-2010-haemodynamic and renal.pdf | 531.63 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
